Clinical Trials Directory

Trials / Completed

CompletedNCT01541683

The Effect of Mentholyptus Drops on the Palatability of PEG-Electrolyte Solution

The Effect of Mentholyptus Drops (Halls®) on the Palatability of PEG-Electrolyte Solution (FORTRANS®) in Colonoscopy Preparation: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
99 (actual)
Sponsor
American University of Beirut Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The investigators aim is to study the efficacy of mentholyptus drops in improving the palatability of PEG-electrolyte solution used in bowel cleansing for colonoscopy. The study is a randomized controlled trial which will include patients undergoing elective colonoscopy at the American University of Beirut Medical Center. Patients will be randomized into one of two study arms using a computer generated randomization list. Patients assigned to the intervention arm will be asked to have candy (Halls®) during the whole 2 hours period while drinking the PEG solution unlike the control arm patients who will only receive the PEG solution. All patients will then be evaluated for the tolerability of the preparation while taking into account the palatability of the solution as main outcome and the remaining volume of the PEG solution and side effects as secondary outcomes.

Conditions

Interventions

TypeNameDescription
OTHERPEG solution (Fortrans®) and Mentholyptus Drops (Halls®)Patients will be instructed to drink 4 Liters of PEG solution (FORTRANS®) split into 2 days while sucking on sugar-free mentholyptus drops (2 L at 7-9 pm on the day prior to the colonoscopy while continuously sucking on Halls®, and 2 L on the day of the colonoscopy to be completed a minimum of 1.5 hours before the procedure while continuously sucking on Halls®)
OTHERPEG solution (Fortrans®)4 liters of PEG solution (FORTRANS®) split into 2 days (2 L at 7-9 pm on the day prior to the colonoscopy, and 2 L on the day of the colonoscopy to be completed a minimum of 1.5 hours before the procedure)

Timeline

Start date
2012-01-01
Primary completion
2013-06-01
Completion
2013-07-01
First posted
2012-03-01
Last updated
2013-08-07

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT01541683. Inclusion in this directory is not an endorsement.